Tobacco Pulse Surveys: Q1 2026

Share on twitter
Share on email
Share on whatsapp
Share on linkedin

Every Sunday, we run a quick poll on the hottest subject in the Tobacco Industry. Hundreds of our Twitter/X followers vote, offering a collective wisdom on the subject matter or an immediate pulse on the market/industry developments.

Results of the Sunday polls:

March 28, 2026

What is your small-cap tobacco (nicotine) stock pick for the next 12 months? (mcap <$2 billion)

– Haypp Group: 44%

– Scandinavian Tobacco: 28%

– Turning Point Brands: 16%

– Other: 12%

March 22, 2026

What drives the next move higher in tobacco stocks?

– Rotation to defensives/value (low beta): 52%

– Improved business fundamentals: 33%

– Rate cuts (less yield competition): 8%

– Bullish market sentiment (new market highs): 8%

March 15, 2026

Looking 20 years ahead, which will be the most valuable nicotine brand in the world?

– ZYN / VELO (pouches): 60%

– IQOS (heated tobacco): 18%

– Marlboro (cigarettes): 17%

– VUSE (vapes): 5%

March 8, 2026

Which tobacco major has the most stretched valuation (vs. earnings, cash flow, balance sheet quality, growth, etc.)?

– Philip Morris International: 46%

– Altria: 34%

– British American Tobacco: 12%

– Imperial Brands: 8%

March 1, 2026

Are tobacco stocks under, fairly or over-valued?

– Fairly valued: 56%

– Undervalued: 28%

– Overvalued: 17%

Feb 22, 2026

Which tobacco company lags its competitors the most in terms of management quality?

– Altria: 61%

– Imperial Brands: 21%

– British American Tobacco: 13%

– Philip Morris International: 5%

Feb 15, 2026

British American Tobacco (BAT) FY25 Results & FY26 Guidance _____ my expectations.

– Meet: 60%

– Beat: 29%

– Miss: 11%

Feb 8, 2026

What will you scrutinize first & foremost in British American Tobacco (BAT) FY25 results (February 12, Thursday)?

– New category performance (VELO, VUSE, glo): 54%

– U.S. cigarette volume/pricing: 17%

– Financial guidance: 15%

– Capital allocation: 14%

Feb 1, 2026

What will you scrutinize first & foremost in Philip Morris International Q4 2025 results (February 6, Friday)?

– ZYN volume/pricing: 47%

– IQOS USA update: 21%

– Financials/Guidance (Revenue, EPS, operating margin, adjustments): 19%

– Heated tobacco growth: 13%

Jan 25, 2026

What will you scrutinize first&foremost in Altria Q4 2025 results?

– Cigarette volume/pricing: 36%

– Nicotine pouch performance (on!): 28%

– Strategic updates (NJOY re-launch, HnB PMTAs, international expansion): 21%

– Financials & Guidance: 15%

Jan 18, 2026

Do you expect Philip Morris International (PMI) share price to hit $200 in 2026?

– Yes: 50%

– No: 50%

Jan 11, 2026

Which tobacco major will deliver the best Total Shareholder Return (share price appreciation plus dividends) over the next 12 months?

– British American Tobacco: 57%

– Philip Morris International: 22%

– Altria: 12%

– Imperial Brands: 9%

Jan 4, 2026

Tobacco stocks outperformed the market in three of the last 4 years. What is your expectation for 2026?

– Market perform: 44%

– Outperform: 41%

– Underperform: 15%

Tobacco Pulse Surveys: Q4 2025

Tobacco Pulse Surveys: Q3 2025

Tobacco Pulse Surveys: Q2 2025

Tobacco Pulse Surveys: Q1 2025

Tobacco Pulse Surveys: Q4 2024

Tobacco Pulse Surveys: Q3 2024

Tobacco Pulse Surveys: Q2 2024

Tobacco Pulse Surveys: Q1 2024

Tobacco Pulse Surveys: Q4 2023

Tags:

Call Request:
Reports

We will reach out to you within 24 hours to discuss your request. Please note that we only respond to requests with a valid business e-mail address
Disclaimer: The content in our Market Pulse section is/shall not be construed as investment advice. It is for informative purposes only and does not take into account the individual needs, investment objectives and specific financial circumstances. Any action taken upon the information in our Market Pulse section is strictly at the reader’s own risk. We assume no responsibility or liability for the actions taken. Moreover, we also assume no responsibility or liability for any errors or omissions in our content – which is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness even if we only depend on the infromation sources that are believed to be accurate.

Consultation
Session Request

We will reach out to you within 24 hours to discuss your request. Please note that we only respond to requests with a valid business e-mail address